Latest Financial Position News

Mesoblast has reported a strong commercial debut for Ryoncil, the first FDA-approved mesenchymal stromal cell therapy for pediatric steroid-refractory acute graft-versus-host disease, generating US$13.2 million in gross revenue in its initial quarter. The company is advancing regulatory and clinical milestones while expanding insurance coverage across the US.

Magnum Mining & Exploration has completed key acquisitions of copper-gold projects in the USA and a rare earths package in Brazil, while raising $0.5 million through a recent entitlement offer to fund exploration and development.

Accelerate Resources has kicked off its maiden drilling campaign at the Kanowna Gold East Project, refining targets through advanced gravity surveys, while bolstering its cash reserves with a $2 million non-dilutive injection.

Dynamic Metals reports encouraging gold assay results from its Widgiemooltha Project, alongside strong cash reserves and upcoming drilling plans at Chalice South.

Talisman Mining ramps up exploration in New South Wales with new gold targets and advances its Mabel Creek IOCG project in South Australia, supported by strong financials and ongoing drilling programs.

Openn Negotiation Ltd moves forward with a creditor-approved recapitalisation plan following voluntary administration, while its shares remain suspended on the ASX.

Openn Negotiation Ltd remains under a Deed of Company Arrangement with no operational activity during the September quarter, focusing on recapitalisation efforts following insolvency and voluntary administration.

Openn Negotiation Ltd has entered voluntary administration following a failed $2.5 million capital raise, with its shares suspended on the ASX. Administrators have secured funding to maintain operations while pursuing a sale or recapitalisation.

Bowen Coking Coal Ltd has been hit with a $6.8 million statutory demand from contractor BUMA Australia, raising the spectre of insolvency if unresolved within 21 days. The dispute centers on claims and counterclaims involving liquidated damages.

Little Green Pharma reported a robust June 2025 quarter with record cash receipts and expanding European footprint, highlighted by a new production capacity in Denmark and the launch of its CherryCo brand in Germany.

Pacific Edge Limited has opened a $5 million Share Purchase Plan at $0.10 per share, conditional on shareholder approval of a prior $16.1 million Placement. The capital raise aims to extend the company’s cash runway and accelerate US market adoption of its bladder cancer diagnostic tests amid Medicare non-coverage.

Vinyl Group Ltd reports a 17% quarterly increase in cash receipts to $3.786 million, driven by acquisitions and platform growth, while targeting cash-flow breakeven by Q2 FY26 through operational efficiencies and margin improvements.